Join EACPT to access new video library of talks on medicines from 2015 Madrid Congress

The EACPT has just released a library of almost 60 videos of talks from the 2015 Madrid

Plaza Major, Madrid

Congress. These videos are now available for EACPT members within the members’ pages of the EACPT website. See below for the list of speakers and their topics, ranging from Alzheimer's to cancer, treating children, regulating medicines, the patient's voice, medicines for low resource global settings, biosimilars, and patient safety.

Access to the videos is free for Individual Associate members of the EACPT.

To view the videos as an existing EACPT member, open the ‘Publications’ drop down menu on the members' pages of the website.



Click here to apply online for EACPT membership.

Anyone from anywhere in the world with a professional interest in clinical pharmacology and/or therapeutics can now join the EACPT as an Individual Associate member.

Membership benefits include:

• Access to videos of talks from EACPT Meetings
• Discounted registration fees for EACPT meetings
• Online access to the Official EACPT Journal - Clinical Therapeutics
• Access to the EACPT’s worldwide network of Individual Associate Members
• Active involvement in EACPT 

If you are an existing Individual Associate member of the EACPT and have any query regarding your membership login details for the website, please contact eacptmembership@kenes.com.

This new portfolio of videos enriches the existing library of videos of talks available on the EACPT members’ website from the EACPT Cardiovascular focus meeting held in Nijmegen in 2014.

Main topics and speakers

Biosimilar medicinal products. How to enhance healthcare systems sustainability without compromising clinical practice.
Martina Weise (Germany), Cristina Avendaño-Solá (Spain), Aleksandra Grozdanova (Macedonia)

Debate on therapeutic innovation: Does industry research meet the needs of society?
Xavier Carné (Spain) vs. Ruth Diazaraque (United Kingdom)

Debate on pharmacoepidemiology databases
Miriam CJM Sturkenboom (The Netherlands) vs. Tom MacDonald (United Kingdom)

Current challenges in cancer treatment.
Luis Paz Ares (Spain)

Novel insights in ADME
Janne Backman (Finland), Amin Rostami (United Kingdom)

Handling medicines in special populations

- Renal function in older people: Emmanuelle Vidal-Petiot (France)

- Rational pharmacotherapy in children: Imti Choonara (United Kingdom)

- Appropriate prescribing in older patients: Beatriz Montero (Spain)

Medicines and Global Health
Nicola Magrini (WHO, Switzerland), Lembit Rägo (WHO, Switzerland). Raj Long (Bill and Melinda Gates Foundation, UK), Antoni Plasencia (Spain)

Drug development for regulatory approval and reimbursement decisions
Beate Wieseler (Germany), Pierre Demolis (France), Bruno Flamion (Belgium)

Key factors for successful research in Europe
Rafael de Andrés Medina (Spain), Jacques Demotes (France), Javier Urzay (Spain)

Implementation of Pharmacogenetics and Personalised Medicine in Clinical Practice
Raul A. Kiivet (Estonia)

Interventions that improve the use of medicines in clinical practice
Tormod K Bjånes (Norway), Romaldas Maciulaitis (Lithuania), Milan Grundmann (Czech Republic), Espen Jimenez-Solem (Denmark), Carl-Olav Stiller (Sweden), Mikkel Christensen (Denmark), Cornelis Kramers (Netherlands), Kirstine Moll Harboe (Denmark), Cándido Hernández-López (Spain)

Biomarkers in Alzheimer clinical research
Claudio Babiloni (Italy)

Medicines regulation, access to medicines and the patient’s voice
Denis Pouchain (France), Nick Meade (United Kingdom), Toni Gilabert (Spain)

Heterogeneity in drug response
Juan Tamargo (Spain), Caridad Pontes (Spain), Eduard Vieta (Spain)

Immunopharmacology of TNF-alpha: disease-transcending therapies
Roman Fischer (Germany), Johannan Brandse (The Netherlands), Marie-Christophe Boissier (France)

Pharmacovigilance - Risk communication to health professionals and citizens
Barbara Rath (Germany), Almath Spooner (Ireland), Frederic Bouder (Netherlands)

Drug Information and Decision Support Systems to support rational drug treatment
Robert Vander Stichele (Belgium), Ylva Böttiger (Sweden)

Hepatitis B reactivation. How to manage the risk?
José Luis Calleja (Spain)

Progressive multifocal leukoencephalopathy. Risk perception in the therapeutic context
Brigitte Keller-Stanislawski (Germany)

Registries for long-term risks
Ignacio García Doval (Spain)

Drug Induced Liver Injury
Raúl Andrade (Spain), Paul Watkins (USA), Michael Merz (Switzerland), Herve Le Louët (France)

Training on medicines regulation
Arantxa Sancho, Martina Weise, Jorge Camarero, Antonio Gomez-Oute